Skip to main content

Facio-Scapulo-Humeral Dystrophy clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Showing trials for
  • AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD)

    Sorry, not currently recruiting here

    A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Adult Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

    Irvine, California and other locations

Last updated: